WA People
BILL · 2021–22 SESSION

SB 5507: Dialysate & dialysis devices

Exempting a manufacturer of certain dialysate and dialysis devices used by home dialysis patients or a manufacturer's agent from the pharmacy practices act and legend drug act.

Summary

  • Requires that pharmacy and legend drug regulations allow manufacturers of commercially available dialysate and home dialysis equipment to sell, possess, deliver, or dispense dialysis devices and those legend drugs directly to a patient.

From the Senate Bill Report (Orig.) (SB 5507), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 10, 2022
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Karen Keiser (D-33)
Introduced
January 10, 2022 in the Senate
Last action
January 10, 2022
Companion bill
HB 1675
Budget
Has a fiscal note

AN ACT Relating to exempting a manufacturer of certain dialysate and dialysis devices used by home dialysis patients or a manufacturer's agent from the pharmacy practices act and legend drug act;

Sponsors

Prime sponsor: Karen Keiser (D-33)

3 co-sponsors (2 Democrats, 1 Republican)

Ron Muzzall R-10John Lovick D-44Claire Wilson D-30

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. First reading, referred to Health & Long Term Care.
  2. Prefiled for introduction.

SB 5507 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page